Site 5030, Emory University School of Medicine NICHD CRS — Atlanta, Georgia

Site 5030, Emory University School of Medicine NICHD CRS is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 5030, Emory University School of Medicine NICHD CRS has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV-1-infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 5030, Emory University School of Medicine NICHD CRS?

Site 5030, Emory University School of Medicine NICHD CRS has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 5030, Emory University School of Medicine NICHD CRS conducted?

Site 5030, Emory University School of Medicine NICHD CRS has 1 clinical trials on record, with 1 currently active. Their work covers HIV-1-infection.

Is Site 5030, Emory University School of Medicine NICHD CRS accredited by Crixeo Health?

Site 5030, Emory University School of Medicine NICHD CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 5030, Emory University School of Medicine NICHD CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.